These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 20086217)

  • 1. Mortality in patients with pituitary disease.
    Sherlock M; Ayuk J; Tomlinson JW; Toogood AA; Aragon-Alonso A; Sheppard MC; Bates AS; Stewart PM
    Endocr Rev; 2010 Jun; 31(3):301-42. PubMed ID: 20086217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mortality and pituitary disease.
    Stewart PM; Sherlock M
    Ann Endocrinol (Paris); 2012 Apr; 73(2):81-2. PubMed ID: 22503666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ACTH deficiency, higher doses of hydrocortisone replacement, and radiotherapy are independent predictors of mortality in patients with acromegaly.
    Sherlock M; Reulen RC; Alonso AA; Ayuk J; Clayton RN; Sheppard MC; Hawkins MM; Bates AS; Stewart PM
    J Clin Endocrinol Metab; 2009 Nov; 94(11):4216-23. PubMed ID: 19808848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality in patients treated for Cushing's disease is increased, compared with patients treated for nonfunctioning pituitary macroadenoma.
    Dekkers OM; Biermasz NR; Pereira AM; Roelfsema F; van Aken MO; Voormolen JH; Romijn JA
    J Clin Endocrinol Metab; 2007 Mar; 92(3):976-81. PubMed ID: 17200171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anterior pituitary dysfunction in survivors of traumatic brain injury.
    Agha A; Rogers B; Sherlock M; O'Kelly P; Tormey W; Phillips J; Thompson CJ
    J Clin Endocrinol Metab; 2004 Oct; 89(10):4929-36. PubMed ID: 15472187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
    Mukherjee A; Murray RD; Teasdale GM; Shalet SM
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquired prolactin deficiency indicates severe hypopituitarism in patients with disease of the hypothalamic-pituitary axis.
    Mukherjee A; Murray RD; Columb B; Gleeson HK; Shalet SM
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):743-8. PubMed ID: 14974916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group.
    Tomlinson JW; Holden N; Hills RK; Wheatley K; Clayton RN; Bates AS; Sheppard MC; Stewart PM
    Lancet; 2001 Feb; 357(9254):425-31. PubMed ID: 11273062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone and pituitary radiotherapy, but not serum insulin-like growth factor-I concentrations, predict excess mortality in patients with acromegaly.
    Ayuk J; Clayton RN; Holder G; Sheppard MC; Stewart PM; Bates AS
    J Clin Endocrinol Metab; 2004 Apr; 89(4):1613-7. PubMed ID: 15070920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update in mortality in GH-treated patients.
    Erfurth EM
    J Clin Endocrinol Metab; 2013 Nov; 98(11):4219-26. PubMed ID: 24030944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic, cardiovascular, and cerebrovascular outcomes in growth hormone-deficient subjects with previous cushing's disease or non-functioning pituitary adenoma.
    Webb SM; Mo D; Lamberts SW; Melmed S; Cavagnini F; Pecori Giraldi F; Strasburger CJ; Zimmermann AG; Woodmansee WW;
    J Clin Endocrinol Metab; 2010 Feb; 95(2):630-8. PubMed ID: 20022992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between plasma levels of ACTH and cortisol in basal states and during the CRH test in normal subjects and patients with hypothalamo-pituitary disorders.
    Bando H; Zhang CY; Takada Y; Takahashi H; Yamasaki R; Saito S
    Tokushima J Exp Med; 1991 Dec; 38(3-4):61-9. PubMed ID: 1668824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No effect of the PPAR-gamma agonist rosiglitazone on ACTH or cortisol secretion in Nelson's syndrome and Cushing's disease in vitro and in vivo.
    Kreutzer J; Jeske I; Hofmann B; Blumcke I; Fahlbusch R; Buchfelder M; Buslei R
    Clin Neuropathol; 2009; 28(6):430-9. PubMed ID: 19919817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential role for retinoic acid in patients with Cushing's disease.
    Pecori Giraldi F; Ambrogio AG; Andrioli M; Sanguin F; Karamouzis I; Corsello SM; Scaroni C; Arvat E; Pontecorvi A; Cavagnini F
    J Clin Endocrinol Metab; 2012 Oct; 97(10):3577-83. PubMed ID: 22851491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acromegaly and Cushing's disease: Persistence of comorbidities after the control of hypersecretion].
    Rochette C; Castinetti F; Brue T
    Ann Endocrinol (Paris); 2016 Oct; 77 Suppl 1():S19-S28. PubMed ID: 28645354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Report on prognosis of diencephalon-pituitary diseases].
    Saito S; Yokoetsu H; Shimizu N
    Nihon Naibunpi Gakkai Zasshi; 1991 Mar; 67 Suppl 2():263-76. PubMed ID: 2065811
    [No Abstract]   [Full Text] [Related]  

  • 17. Does acromegaly enhance mortality?
    Ayuk J; Sheppard MC
    Rev Endocr Metab Disord; 2008 Mar; 9(1):33-9. PubMed ID: 18075787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apparently complete restoration of normal daily adrenocorticotropin, cortisol, growth hormone, and prolactin secretory dynamics in adults with Cushing's disease after clinically successful transsphenoidal adenomectomy.
    Veldman RG; Frölich M; Pincus SM; Veldhuis JD; Roelfsema F
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4039-46. PubMed ID: 11095430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conventional pituitary irradiation is effective in lowering serum growth hormone and insulin-like growth factor-I in patients with acromegaly.
    Jenkins PJ; Bates P; Carson MN; Stewart PM; Wass JA
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1239-45. PubMed ID: 16403824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of pioglitazone on adrenocorticotropic hormone and cortisol secretion in Cushing's disease.
    Suri D; Weiss RE
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1340-6. PubMed ID: 15585550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.